Clinical Trial Update: Reduced Exposure Study Using THS 2.2 Menthol With 5 Days in a Confinement Setting and 85 Days in an Ambulatory Setting [NA]

View source ↗

Summary

Clinical trial update for a reduced exposure study of THS 2.2 Menthol in confinement and ambulatory settings; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Smoking

Drugs mentioned

• THS 2.2 Menthol (null)

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Smoking | NA | Status: COMPLETED | Results posted: 2017-02-07